Fayssoil, A.; Davido, B.; Mustafic, H.; Dinh, A.; Mansencal, N. Heart in Patients Infected with 2019 Novel Coronavirus (COVID-19). Preprints2020, 2020040346. https://doi.org/10.20944/preprints202004.0346.v1
APA Style
Fayssoil, A., Davido, B., Mustafic, H., Dinh, A., & Mansencal, N. (2020). Heart in Patients Infected with 2019 Novel Coronavirus (COVID-19). Preprints. https://doi.org/10.20944/preprints202004.0346.v1
Chicago/Turabian Style
Fayssoil, A., Aurélien Dinh and Nicolas Mansencal. 2020 "Heart in Patients Infected with 2019 Novel Coronavirus (COVID-19)" Preprints. https://doi.org/10.20944/preprints202004.0346.v1
Abstract
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is an emerging infectious disease with currently a pandemic state. Cardiac function can be involved, affecting prognosis, in addition with lung feature severity, particularly in patients with comorbidities. Since the renin angiotensin aldosterone (RAA) system may interact with SARS-Cov-2, researches are still ongoing to assess the prognostic value of RAA blockers in cardiology.
Keywords
coronavirus; heart; prognosis; COVID-19; ICU
Subject
Medicine and Pharmacology, Cardiac and Cardiovascular Systems
Copyright:
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
